{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:32:39Z","timestamp":1761921159284,"version":"3.40.5"},"reference-count":125,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.msard.2023.105027","type":"journal-article","created":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T13:41:45Z","timestamp":1695562905000},"page":"105027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Co-occurrence of glioma and multiple sclerosis: Prevailing theories and emerging therapies"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3463-5018","authenticated-orcid":false,"given":"Enoch","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marla C.","family":"Fortoul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Weimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Meggyesy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0244-0005","authenticated-orcid":false,"given":"Michelle","family":"Demory Beckler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.msard.2023.105027_bib0081","first-page":"127","article-title":"Role of dimethyl fumarate in the treatment of glioblastoma multiforme: a review article","volume":"18","author":"Ahmadi-Beni","year":"2019","journal-title":"Iran. J. Neurol."},{"key":"10.1016\/j.msard.2023.105027_bib0118","first-page":"149","article-title":"Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods","volume":"6","author":"Ahmed","year":"2014","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.msard.2023.105027_bib0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/jfmk3010013","article-title":"Insights into the role of neuroinflammation in the pathogenesis of multiple sclerosis","volume":"3","author":"Al-Badri","year":"2018","journal-title":"J. Funct. Morphol. Kinesiol."},{"key":"10.1016\/j.msard.2023.105027_bib0121","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102877","article-title":"The concurrence of multiple sclerosis and glioblastoma","volume":"50","author":"Alkabie","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.msard.2023.105027_bib0046","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF01057961","article-title":"Lack of association of human polyomaviruses with human brain tumors","volume":"20","author":"Arthur","year":"1994","journal-title":"J. Neurooncol."},{"issue":"6","key":"10.1016\/j.msard.2023.105027_bib0099","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000439278","article-title":"Short-term effect of high-dose vitamin D on the level of interleukin 10 in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial","volume":"22","author":"Ashtari","year":"2015","journal-title":"Neuroimmunomodulation"},{"issue":"5","key":"10.1016\/j.msard.2023.105027_bib0036","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000274","article-title":"Nonfatal PML in a patient with multiple sclerosis treated with dimethyl fumarate","volume":"3","author":"Baharnoori","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"13","key":"10.1016\/j.msard.2023.105027_bib0019","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1212\/01.wnl.0000345366.10455.62","article-title":"Cancer risk among patients with multiple sclerosis and their parents","volume":"72","author":"Bahmanyar","year":"2009","journal-title":"Neurology"},{"issue":"16","key":"10.1016\/j.msard.2023.105027_bib0059","doi-asserted-by":"crossref","first-page":"7843","DOI":"10.1158\/0008-5472.CAN-06-1010","article-title":"Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor","volume":"66","author":"Bao","year":"2006","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.msard.2023.105027_bib0088","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s40265-014-0212-x","article-title":"Teriflunomide and its mechanism of action in multiple sclerosis","volume":"74","author":"Bar-Or","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.msard.2023.105027_bib0022","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3171\/jns.1963.20.2.0122","article-title":"The problem of multicentric gliomas","volume":"20","author":"Batzdorf","year":"1963","journal-title":"J. Neurosurg."},{"issue":"20","key":"10.1016\/j.msard.2023.105027_bib0073","doi-asserted-by":"crossref","first-page":"e1815","DOI":"10.1212\/WNL.0000000000005529","article-title":"Progressive multifocal leukoencephalopathy after fingolimod treatment","volume":"90","author":"Berger","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.105027_bib0074","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.msard.2017.01.006","article-title":"Classifying PML risk with disease modifying therapies","volume":"12","author":"Berger","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"4","key":"10.1016\/j.msard.2023.105027_bib0014","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/19418744221106003","article-title":"Glioblastoma in patients with multiple sclerosis","volume":"12","author":"Berkman","year":"2022","journal-title":"Neurohospitalist"},{"issue":"2","key":"10.1016\/j.msard.2023.105027_bib0043","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1128\/jvi.63.2.863-872.1989","article-title":"Hybrid genomes of the polyomaviruses JC virus, BK virus, and simian virus 40: identification of sequences important for efficient transformation","volume":"63","author":"Bollag","year":"1989","journal-title":"J. Virol."},{"issue":"36","key":"10.1016\/j.msard.2023.105027_bib0082","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1038\/onc.2011.563","article-title":"EGFRvIII promotes glioma angiogenesis and growth through the NF-\u03baB, interleukin-8 pathway","volume":"31","author":"Bonavia","year":"2012","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.msard.2023.105027_bib0035","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.3390\/jcm10091998","article-title":"JC virus seroprevalence and JCVAb index in polish multiple sclerosis patients treated with immunomodulating or immunosuppressive therapies","volume":"10","author":"Bonek","year":"2021","journal-title":"J. Clin. Med."},{"issue":"11","key":"10.1016\/j.msard.2023.105027_bib0111","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.3390\/cancers12113163","article-title":"Effect of 1\u03b1,25(OH)2 Vitamin D3 in Mutant P53 glioblastoma cells: involvement of neutral sphingomyelinase1","volume":"12","author":"Cataldi","year":"2020","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.msard.2023.105027_bib0064","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/WNF.0b013e3181cbf825","article-title":"Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis","volume":"33","author":"Chun","year":"2010","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.msard.2023.105027_bib0027","first-page":"321","article-title":"Microglia, an in vivo source of reactive oxygen species in the brain","volume":"59","author":"Colton","year":"1993","journal-title":"Adv. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2023.105027_bib0090","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1474-4422(13)70308-9","article-title":"Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"13","author":"Confavreux","year":"2014","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.msard.2023.105027_bib0044","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1212\/WNL.58.6.895","article-title":"Expression of JC virus T-antigen in a patient with MS and glioblastoma multiforme","volume":"58","author":"Del Valle","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.105027_bib0041","doi-asserted-by":"crossref","DOI":"10.1186\/s13027-017-0122-0","article-title":"Review on the role of the human polyomavirus JC in the development of tumors","volume":"12","author":"Delbue","year":"2017","journal-title":"Infect Agent Cancer"},{"issue":"9","key":"10.1016\/j.msard.2023.105027_bib0025","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.msard.2023.105027_bib0126","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fonc.2020.00022","article-title":"Fingolimod augments monomethylfumarate killing of GBM cells","volume":"10","author":"Dent","year":"2020","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.msard.2023.105027_bib0087","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s13311-021-01073-y","article-title":"Association between disease-modifying therapies prescribed to persons with multiple sclerosis and cancer: a WHO pharmacovigilance database analysis","volume":"18","author":"Dolladille","year":"2021","journal-title":"Neurotherapeutics"},{"issue":"7","key":"10.1016\/j.msard.2023.105027_bib0052","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1172\/JCI8970","article-title":"Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis","volume":"105","author":"Duda","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.msard.2023.105027_bib0042","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0092-8674(89)90839-8","article-title":"The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus","volume":"58","author":"Dyson","year":"1989","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.msard.2023.105027_bib0105","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/bcpt.13007","article-title":"Vitamin D analogues tacalcitol and calcipotriol inhibit proliferation and migration of T98G human glioblastoma cells","volume":"123","author":"Emanuelsson","year":"2018","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.msard.2023.105027_bib0070","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/neuonc\/nos005","article-title":"Induction of brain tumor stem cell apoptosis by FTY720: a potential therapeutic agent for glioblastoma","volume":"14","author":"Estrada-Bernal","year":"2012","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.msard.2023.105027_bib0106","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jsbmb.2017.10.019","article-title":"Antitumoral effects of the alkynylphosphonate analogue of calcitriol EM1 on glioblastoma multiforme cells","volume":"178","author":"Ferronato","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.msard.2023.105027_bib0107","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jsbmb.2018.08.006","article-title":"Synthesis of a novel analog of calcitriol and its biological evaluation as antitumor agent","volume":"185","author":"Ferronato","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.msard.2023.105027_bib0075","unstructured":"Fox R.C.B, Greenberg B., Hemmer B., Ward B.J., Ontaneda D., Moore A., Zhang Y., Sullivan R., Girase P., Hach T., Berger J.R. Update on the risk estimates of progressive multifocal leukoencephalopathy related to fingolimod. MSVirtual 2020. 2020; Abstract FC02.02."},{"issue":"6","key":"10.1016\/j.msard.2023.105027_bib0023","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.it.2018.01.005","article-title":"Reactive oxygen species: involvement in T cell signaling and metabolism","volume":"39","author":"Franchina","year":"2018","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.msard.2023.105027_bib0092","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac171","article-title":"Full spectrum of vitamin D immunomodulation in multiple sclerosis: mechanisms and therapeutic implications","volume":"4","author":"Galoppin","year":"2022","journal-title":"Brain Commun."},{"issue":"1","key":"10.1016\/j.msard.2023.105027_bib0006","first-page":"1","article-title":"Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy","volume":"19","author":"Ghasemi","year":"2017","journal-title":"Cell J."},{"key":"10.1016\/j.msard.2023.105027_bib0084","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4103\/2152-7806.123656","article-title":"Beneficial actions of the anti-inflammatory dimethyl fumarate in glioblastomas","volume":"4","author":"Ghods","year":"2013","journal-title":"Surg. Neurol. Int."},{"issue":"4","key":"10.1016\/j.msard.2023.105027_bib0114","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3390\/jpm11040258","article-title":"Diagnosis and management of glioblastoma: a comprehensive perspective","volume":"11","author":"Gilard","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.msard.2023.105027_bib0055","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3389\/fphar.2020.00368","article-title":"Targeting tumor associated macrophages to overcome conventional treatment resistance in glioblastoma","volume":"11","author":"Gr\u00e9goire","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.msard.2023.105027_bib0085","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00001813-200502000-00008","article-title":"Enhanced cytotoxicity of bioreductive antitumor agents with dimethyl fumarate in human glioblastoma cells","volume":"16","author":"Gu","year":"2005","journal-title":"Anticancer Drugs"},{"issue":"3","key":"10.1016\/j.msard.2023.105027_bib0003","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4103\/1673-5374.245462","article-title":"The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to in vivo imaging","volume":"14","author":"Guan","year":"2019","journal-title":"Neural Regen. Res."},{"issue":"19","key":"10.1016\/j.msard.2023.105027_bib0037","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1212\/WNL.0000000000002654","article-title":"Fingolimod-associated PML in a patient with prior immunosuppression","volume":"86","author":"Gyang","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.105027_bib0100","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jneuroim.2016.03.011","article-title":"Hypovitaminosis D upscales B-cell immunoreactivity in multiple sclerosis","volume":"294","author":"Haas","year":"2016","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.msard.2023.105027_bib0077","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12974-016-0559-x","article-title":"Dimethyl fumarate attenuates experimental autoimmune neuritis through the nuclear factor erythroid-derived 2-related factor 2\/hemoxygenase-1 pathway by altering the balance of M1\/M2 macrophages","volume":"13","author":"Han","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.msard.2023.105027_bib0062","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/948098","article-title":"Macrophages in tumor microenvironments and the progression of tumors","volume":"2012","author":"Hao","year":"2012","journal-title":"Clin. Dev. Immunol."},{"issue":"2","key":"10.1016\/j.msard.2023.105027_bib0096","first-page":"54","article-title":"Association of serum 25(OH) Vitamin D3 concentration with severity of multiple sclerosis","volume":"11","author":"Harandi","year":"2012","journal-title":"Iran. J. Neurol."},{"issue":"12","key":"10.1016\/j.msard.2023.105027_bib0123","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2020.05.049","article-title":"Treatment of multiple sclerosis: a review","volume":"133","author":"Hauser","year":"2020","journal-title":"Am. J. Med."},{"issue":"4","key":"10.1016\/j.msard.2023.105027_bib0026","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ncpneuro0154","article-title":"Immunopathogenesis and immunotherapy of multiple sclerosis","volume":"2","author":"Hemmer","year":"2006","journal-title":"Nat. Clin. Pract. Neurol."},{"issue":"9","key":"10.1016\/j.msard.2023.105027_bib0017","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/neuonc\/not070","article-title":"Subsequent brain tumors in patients with autoimmune disease","volume":"15","author":"Hemminki","year":"2013","journal-title":"Neuro. Oncol."},{"issue":"18","key":"10.1016\/j.msard.2023.105027_bib0054","doi-asserted-by":"crossref","first-page":"6449","DOI":"10.1073\/pnas.0502187102","article-title":"Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3","volume":"102","author":"Hong","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.msard.2023.105027_bib0102","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1177\/1352458513489756","article-title":"The effect of Vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis","volume":"19","author":"James","year":"2013","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.msard.2023.105027_bib0086","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/1352458520949158","article-title":"Progressive multifocal leukoencephalopathy in dimethyl fumarate-treated multiple sclerosis patients","volume":"28","author":"Jordan","year":"2022","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.msard.2023.105027_bib0015","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11060-012-0888-2","article-title":"Genetic characterization of gliomas arising in patients with multiple sclerosis","volume":"109","author":"Khalil","year":"2012","journal-title":"J. Neurooncol."},{"issue":"13","key":"10.1016\/j.msard.2023.105027_bib0031","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1212\/01.wnl.0000257832.38943.2b","article-title":"Reactivation of JC virus and development of PML in patients with multiple sclerosis","volume":"68","author":"Khalili","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2023.105027_bib0120","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1017\/S031716710000425X","article-title":"Concurrence of glioma and multiple sclerosis","volume":"32","author":"Khan","year":"2005","journal-title":"Can. J. Neurol. Sci."},{"issue":"6","key":"10.1016\/j.msard.2023.105027_bib0051","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2165\/11591110-000000000-00000","article-title":"The mechanism of action of interferon-\u03b2 in relapsing multiple sclerosis","volume":"25","author":"Kieseier","year":"2011","journal-title":"CNS Drugs"},{"issue":"11","key":"10.1016\/j.msard.2023.105027_bib0048","doi-asserted-by":"crossref","first-page":"7144","DOI":"10.4049\/jimmunol.172.11.7144","article-title":"Type 2 monocyte and microglia differentiation mediated by glatiramer acetate therapy in patients with multiple sclerosis","volume":"172","author":"Kim","year":"2004","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.msard.2023.105027_bib0032","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJMoa051782","article-title":"Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis","volume":"353","author":"Kleinschmidt-DeMasters","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.msard.2023.105027_bib0050","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3390\/pharmaceutics14020344","article-title":"Manipulating macrophage\/microglia polarization to treat glioblastoma or multiple sclerosis","volume":"14","author":"Kuntzel","year":"2022","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.msard.2023.105027_bib0033","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1056\/NEJMoa051847","article-title":"Progressive multifocal leukoencephalopathy in a patient treated with natalizumab","volume":"353","author":"Langer-Gould","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"10145","key":"10.1016\/j.msard.2023.105027_bib0007","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(18)30990-5","article-title":"Primary brain tumours in adults","volume":"392","author":"Lapointe","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.msard.2023.105027_bib0122","doi-asserted-by":"crossref","DOI":"10.12786\/bn.2022.15.e24","article-title":"Treatment of adult gliomas: a current update","volume":"15","author":"Lee","year":"2022","journal-title":"Brain Neurorehabil."},{"issue":"2","key":"10.1016\/j.msard.2023.105027_bib0104","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41374-021-00673-8","article-title":"Anti-tumor effects of vitamin D in glioblastoma: mechanism and therapeutic implications","volume":"102","author":"Lo","year":"2022","journal-title":"Lab. Invest."},{"issue":"5","key":"10.1016\/j.msard.2023.105027_bib0060","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1189\/jlb.0908579","article-title":"Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1- and MMP-9-dependent pathways","volume":"85","author":"Lolmede","year":"2009","journal-title":"J. Leukoc. Biol."},{"issue":"4362","key":"10.1016\/j.msard.2023.105027_bib0039","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1126\/science.211583","article-title":"Brain tumors in owl monkeys inoculated with a human polyomavirus (JC virus)","volume":"201","author":"London","year":"1978","journal-title":"Science"},{"key":"10.1016\/j.msard.2023.105027_bib0040","first-page":"227","article-title":"Viral-induced astrocytomas in squirrel monkeys","volume":"105","author":"London","year":"1983","journal-title":"Prog. Clin. Biol. Res."},{"issue":"8","key":"10.1016\/j.msard.2023.105027_bib0010","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro. Oncol."},{"issue":"7","key":"10.1016\/j.msard.2023.105027_bib0110","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s007010050166","article-title":"Vitamin D metabolites activate the sphingomyelin pathway and induce death of glioblastoma cells","volume":"140","author":"Magrassi","year":"1998","journal-title":"Acta Neurochir."},{"issue":"6","key":"10.1016\/j.msard.2023.105027_bib0076","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000401","article-title":"Impaired T-cell migration to the CNS under fingolimod and dimethyl fumarate","volume":"4","author":"Mathias","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"12","key":"10.1016\/j.msard.2023.105027_bib0103","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1007\/s00415-018-9074-6","article-title":"Vitamin D for the treatment of multiple sclerosis: a meta-analysis","volume":"265","author":"McLaughlin","year":"2018","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2023.105027_bib0008","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ncl.2016.06.014","article-title":"Epidemiology of brain tumors","volume":"34","author":"McNeill","year":"2016","journal-title":"Neurol. Clin."},{"issue":"6","key":"10.1016\/j.msard.2023.105027_bib0016","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1600-0404.1996.tb00019.x","article-title":"Multiple sclerosis and cancer in Norway. A retrospective cohort study","volume":"93","author":"Midgard","year":"1996","journal-title":"Acta Neurol. Scand."},{"issue":"1","key":"10.1016\/j.msard.2023.105027_bib0119","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/neuonc\/noac207","article-title":"Isocitrate dehydrogenase (IDH) mutant gliomas: a society for neuro-oncology (SNO) consensus review on diagnosis, management, and future directions","volume":"25","author":"Miller","year":"2023","journal-title":"Neuro Oncol."},{"issue":"11","key":"10.1016\/j.msard.2023.105027_bib0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003622","article-title":"Mortality following a brain tumour diagnosis in patients with multiple sclerosis","volume":"3","author":"Montgomery","year":"2013","journal-title":"BMJ Open"},{"issue":"3\u20134","key":"10.1016\/j.msard.2023.105027_bib0013","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1600-0447.1949.tb07342.x","article-title":"A case of disseminated sclerosis and glioma of the brain in the same patient","volume":"24","author":"Munch-Petersen","year":"1949","journal-title":"Acta Psychiatr. Neurol."},{"key":"10.1016\/j.msard.2023.105027_bib0098","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jneuroim.2016.09.018","article-title":"Immune regulatory effects of high dose vitamin D3 supplementation in a randomized controlled trial in relapsing remitting multiple sclerosis patients receiving IFN\u03b2; the SOLARIUM study","volume":"300","author":"Muris","year":"2016","journal-title":"J. Neuroimmunol."},{"issue":"14","key":"10.1016\/j.msard.2023.105027_bib0089","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa1014656","article-title":"Randomized trial of oral teriflunomide for relapsing multiple sclerosis","volume":"365","author":"O'Connor","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2023.105027_bib0113","first-page":"S1","article-title":"Multiple sclerosis: diagnosis and differential diagnosis","volume":"55","author":"\u00d6merhoca","year":"2018","journal-title":"Noro Psikiyatr Ars"},{"issue":"Pt B","key":"10.1016\/j.msard.2023.105027_bib0063","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.neuropharm.2016.11.006","article-title":"Sphingosine-1-phosphate receptor therapies: advances in clinical trials for CNS-related diseases","volume":"113","author":"O'Sullivan","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.msard.2023.105027_bib0012","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/878425","article-title":"Current trends in targeted therapies for glioblastoma multiforme","volume":"2012","author":"Ohka","year":"2012","journal-title":"Neurol. Res. Int."},{"key":"10.1016\/j.msard.2023.105027_bib0024","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.expneurol.2015.11.010","article-title":"Oxidative stress in multiple sclerosis: central and peripheral mode of action","volume":"277","author":"Ohl","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.msard.2023.105027_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.620677","article-title":"Drug resistance in glioblastoma: the two faces of oxidative stress","volume":"7","author":"Olivier","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.msard.2023.105027_bib0004","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrneurol.2016.187","article-title":"Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis","volume":"13","author":"Olsson","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2023.105027_bib0009","doi-asserted-by":"crossref","first-page":"iii1","DOI":"10.1093\/neuonc\/noac161","article-title":"CBTRUS statistical report: pediatric brain tumor foundation childhood and adolescent primary brain and other central nervous system tumors diagnosed in the United States in 2014-2018","volume":"24","author":"Ostrom","year":"2022","journal-title":"Neuro. Oncol."},{"issue":"7","key":"10.1016\/j.msard.2023.105027_bib0034","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1177\/1352458513505353","article-title":"JC-virus seroconversion in multiple sclerosis patients receiving natalizumab","volume":"20","author":"Outteryck","year":"2014","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.msard.2023.105027_bib0065","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1074\/jbc.M807170200","article-title":"Interleukin-1 regulates the expression of sphingosine kinase 1 in glioblastoma cells","volume":"284","author":"Paugh","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.msard.2023.105027_bib0058","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/neuonc\/nos158","article-title":"Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype","volume":"14","author":"Piao","year":"2012","journal-title":"Neuro. Oncol."},{"issue":"2","key":"10.1016\/j.msard.2023.105027_bib0053","article-title":"The evolving mechanisms of action of glatiramer acetate","volume":"9","author":"Prod'homme","year":"2019","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"4616","key":"10.1016\/j.msard.2023.105027_bib0093","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1126\/science.6310748","article-title":"Manolagas SC. 1,25-dihydroxyvitamin D3 receptors in human leukocytes","volume":"221","author":"Provvedini","year":"1983","journal-title":"Science"},{"issue":"49","key":"10.1016\/j.msard.2023.105027_bib0080","doi-asserted-by":"crossref","first-page":"6938","DOI":"10.1038\/sj.onc.1203221","article-title":"Aberrant rel\/nfkb genes and activity in human cancer","volume":"18","author":"Rayet","year":"1999","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.msard.2023.105027_bib0021","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/jnnp.36.4.523","article-title":"Multiple cerebral gliomas in multiple sclerosis","volume":"36","author":"Reagan","year":"1973","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/j.msard.2023.105027_bib0028","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3390\/ijms17060984","article-title":"ROS and brain gliomas: an overview of potential and innovative therapeutic strategies","volume":"17","author":"Rinaldi","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.msard.2023.105027_bib0045","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/ijc.20641","article-title":"Investigation of human brain tumors for the presence of polyomavirus genome sequences by two independent laboratories","volume":"113","author":"Rollison","year":"2005","journal-title":"Int. J. Cancer"},{"issue":"9017","key":"10.1016\/j.msard.2023.105027_bib0002","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(96)90807-7","article-title":"Evidence for genetic basis of multiple sclerosis. The Canadian collaborative study group","volume":"347","author":"Sadovnick","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2023.105027_bib0029","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fimmu.2016.00156","article-title":"Role of redox status in development of glioblastoma","volume":"7","author":"Salazar-Ramiro","year":"2016","journal-title":"Front. Immunol."},{"issue":"17","key":"10.1016\/j.msard.2023.105027_bib0078","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1073\/pnas.1603907113","article-title":"Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2","volume":"113","author":"Schulze-Topphoff","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.msard.2023.105027_bib0125","article-title":"Phase I trial of dimethyl fumarate, temozolomide, and radiation therapy in glioblastoma","volume":"2","author":"Shafer","year":"2020","journal-title":"Neurooncol. Adv."},{"issue":"5","key":"10.1016\/j.msard.2023.105027_bib0097","first-page":"585","article-title":"Vitamin d3 concentration correlates with the severity of multiple sclerosis","volume":"4","author":"Shahbeigi","year":"2013","journal-title":"Int. J. Prev. Med."},{"issue":"9","key":"10.1016\/j.msard.2023.105027_bib0091","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2022.07.011","article-title":"De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant glioma","volume":"40","author":"Shi","year":"2022","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.msard.2023.105027_bib0095","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1177\/1352458508094399","article-title":"Association of Vitamin D metabolite levels with relapse rate and disability in multiple sclerosis","volume":"14","author":"Smolders","year":"2008","journal-title":"Mult. Scler."},{"issue":"5","key":"10.1016\/j.msard.2023.105027_bib0018","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000079947","article-title":"Cancer incidence in multiple sclerosis: a 35-year follow-up","volume":"23","author":"Sumelahti","year":"2004","journal-title":"Neuroepidemiology"},{"issue":"10","key":"10.1016\/j.msard.2023.105027_bib0011","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1158\/1055-9965.EPI-14-0275","article-title":"Epidemiologic and molecular prognostic review of glioblastoma","volume":"23","author":"Thakkar","year":"2014","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"2","key":"10.1016\/j.msard.2023.105027_bib0112","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.msard.2023.105027_bib0116","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1756285613478870","article-title":"Neuroradiological evaluation of demyelinating disease","volume":"6","author":"Tillema","year":"2013","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.msard.2023.105027_bib0115","doi-asserted-by":"crossref","first-page":"iii11","DOI":"10.1136\/jnnp.2005.073213","article-title":"Imaging in multiple sclerosis","volume":"76","author":"Trip","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.msard.2023.105027_bib0067","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0304-3835(02)00050-2","article-title":"Sphingosine-1-phosphate stimulates human glioma cell proliferation through Gi-coupled receptors: role of ERK MAP kinase and phosphatidylinositol 3-kinase beta","volume":"181","author":"Van Brocklyn","year":"2002","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.msard.2023.105027_bib0066","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0304-3835(03)00334-3","article-title":"Sphingosine-1-phosphate stimulates motility and invasiveness of human glioblastoma multiforme cells","volume":"199","author":"Van Brocklyn","year":"2003","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.msard.2023.105027_bib0061","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1021\/mp1004228","article-title":"The suppressive tumor microenvironment: a challenge in cancer immunotherapy","volume":"8","author":"Vasievich","year":"2011","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.msard.2023.105027_bib0094","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/BF00373840","article-title":"Expression of sodium-dependent phosphate (NadPi) transport in Xenopus laevis oocytes induced by mRNA from 1 alpha, 25-dihydroxyvitamin D3-treated rat osteoblast-like cells","volume":"430","author":"Veldman","year":"1995","journal-title":"Pflugers Arch."},{"issue":"9","key":"10.1016\/j.msard.2023.105027_bib0049","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.4049\/jimmunol.170.9.4483","article-title":"Glatiramer acetate (copolymer-1, copaxone) promotes Th2 cell development and increased IL-10 production through modulation of dendritic cells","volume":"170","author":"Vieira","year":"2003","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.msard.2023.105027_bib0117","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/neuros\/nyx103","article-title":"Current clinical brain tumor imaging","volume":"81","author":"Villanueva-Meyer","year":"2017","journal-title":"Neurosurgery"},{"key":"10.1016\/j.msard.2023.105027_bib0108","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fendo.2012.00058","article-title":"Vitamin D and cancer","volume":"3","author":"Vuolo","year":"2012","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.msard.2023.105027_bib0057","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1097-0215(19990702)82:1<12::AID-IJC3>3.0.CO;2-O","article-title":"Microglial\/macrophage expression of interleukin 10 in human glioblastomas","volume":"82","author":"Wagner","year":"1999","journal-title":"Int. J. Cancer"},{"issue":"4100","key":"10.1016\/j.msard.2023.105027_bib0038","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1126\/science.181.4100.674","article-title":"Human papovavirus (JC): induction of brain tumors in hamsters","volume":"181","author":"Walker","year":"1973","journal-title":"Science"},{"issue":"14","key":"10.1016\/j.msard.2023.105027_bib0001","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler."},{"issue":"Pt 6","key":"10.1016\/j.msard.2023.105027_bib0047","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/brain\/awh163","article-title":"Multiple sclerosis: glatiramer acetate inhibits monocyte reactivity in vitro and in vivo","volume":"127","author":"Weber","year":"2004","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.msard.2023.105027_bib0079","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1158\/2326-6066.CIR-14-0112","article-title":"NF-\u03baB, an active player in human cancers","volume":"2","author":"Xia","year":"2014","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.msard.2023.105027_bib0109","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3892\/ol.2017.6221","article-title":"Epidermal growth factor receptor in glioblastoma","volume":"14","author":"Xu","year":"2017","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.msard.2023.105027_bib0083","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.molcel.2012.09.028","article-title":"EGFR-induced and PKC\u03b5 monoubiquitylation-dependent NF-\u03baB activation upregulates PKM2 expression and promotes tumorigenesis","volume":"48","author":"Yang","year":"2012","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.msard.2023.105027_bib0056","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4049\/jimmunol.1103248","article-title":"Tumor-associated microglia\/macrophages enhance the invasion of glioma stem-like cells via TGF-\u03b21 signaling pathway","volume":"189","author":"Ye","year":"2012","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.msard.2023.105027_bib0072","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1002\/ijc.24933","article-title":"Sphingosine-1-phosphate receptor type 1 regulates glioma cell proliferation and correlates with patient survival","volume":"126","author":"Yoshida","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.msard.2023.105027_bib0071","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.pharep.2017.07.003","article-title":"FTY720 inhibits the Nrf2\/ARE pathway in human glioblastoma cell lines and sensitizes glioblastoma cells to temozolomide","volume":"69","author":"Zhang","year":"2017","journal-title":"Pharmacol. Rep."},{"issue":"11","key":"10.1016\/j.msard.2023.105027_bib0068","doi-asserted-by":"crossref","first-page":"10707","DOI":"10.1007\/s13277-014-2386-y","article-title":"FTY720 reduces migration and invasion of human glioblastoma cell lines via inhibiting the PI3K\/AKT\/mTOR\/p70S6K signaling pathway","volume":"35","author":"Zhang","year":"2014","journal-title":"Tumour Biol."},{"issue":"1","key":"10.1016\/j.msard.2023.105027_bib0069","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.toxlet.2015.04.015","article-title":"FTY720 induces autophagy-related apoptosis and necroptosis in human glioblastoma cells","volume":"236","author":"Zhang","year":"2015","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.msard.2023.105027_bib0101","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.msard.2018.05.008","article-title":"The efficacy of Vitamin D in multiple sclerosis: a meta-analysis","volume":"23","author":"Zheng","year":"2018","journal-title":"Mult. Scler. Relat. Disord."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482300528X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482300528X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T21:17:40Z","timestamp":1730150260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221103482300528X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":125,"alternative-id":["S221103482300528X"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2023.105027","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-occurrence of glioma and multiple sclerosis: Prevailing theories and emerging therapies","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2023.105027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105027"}}